COMP <GO>
LIFE vs BRK-A // GROSS PROFIT MARGIN
Ethos Technologies Inc. (Class A) (NASDAQ) VS. Berkshire Hathaway Inc. (Class A) (NYSE) • 15-METRIC TALLY: LIFE 3
— BRK-A 7
■ METRIC PARITY
LAST: $43.62 (+1.85%) • MKT CAP: $2.83B
gross-margins
—
LAST: $817,500.00 (+0.68%) • MKT CAP: $1.20T
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LIFE VS. BRK-A)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LIFE | BRK-A | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 40.60% | 11.47% | +29.13 | LIFE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 37.0x | 9.7x | +27.32 | BRK-A | /valuation <GO> |
| Free Cash Flow Yield | 1.23% | 2.09% | -0.86 | BRK-A | /fcf-yield <GO> |
| Operating Margin | 18.80% | 27.80% | -9.00 | BRK-A | /operating-margins <GO> |
| Net Profit Margin | 18.40% | 22.30% | -3.90 | BRK-A | /net-margins <GO> |
| Revenue Growth (YoY) | 52.00% | 3.93% | +48.07 | LIFE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | LIFE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.8 | 68.1 | -2.30 | BRK-A | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.13 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.4x | 24.3x | +9.06 | BRK-A | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.83B | $1.20T | -$1.20T | BRK-A | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LIFE REV | BRK-A REV | LIFE GROSS % | BRK-A GROSS % | LIFE FCF | BRK-A FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $387.6M | $247.24B | — | — | $34.7M | $25.04B |
| FY 2024 | $254.9M | $249.71B | — | — | -$11.7M | $11.62B |
| FY 2023 | — | $254.91B | — | — | — | $37.73B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LIFE // BETA —
BRK-A // BETA 1.13